bioRxivImmunologyPreprint
ediTONSIL: Activation-Neutral Gene Editing of CD4 T cells in Human ex Vivo Tonsil Cultures
K. Morath, L. Sadhu, G. Dyckhoff, M. Gapp, O. T. Keppler, O. T. Fackler
Abstract
MotivationCD4 T cells are central players of adaptive immunity that rapidly change activation states in response to exogenous T cell receptor (TCR) stimulation. While molecular processes in activated human CD4 T cells from peripheral blood are well studied, resting CD4 T cells are refractory to gene-editing transduction and transfection methods without prior activation. Knowledge on the molecular biology of truly resting CD4 T cells is therefore lacking. We present here the culture and editing workflow ediTONSIL that allows for gene editing of tissue-resident CD4 T cells without compromising their activation state or immunological function. This will enable molecular mechanistic analyses of this cell type in their native/physiological tissue context. SummaryThe molecular and immunological properties of resting CD4 T cell biology are understudied due to the lack of suitable gene editing methods. Here we describe the ex vivo culture and gene editing methodology ediTONSIL for tissue-resident CD4 T cells from human tonsil tissue. CRISPR/Cas9 RNP nucleofection under optimized culture conditions and cytokine concentrations results in knock out efficacies of over 90%, which are e.g. sufficient to prevent HIV-1 infection when targeting the viral entry co-receptor CXCR4. EdiTONSIL does not impair tonsil CD4 T cell viability, activation state or immunocompetence and does not require exogenous activation. Editing can be performed on multiple cell types in bulk cultures or of CD4 T cells previously isolated from tonsils that can be added back to the non-CD4 T cell fraction post gene editing to reassemble into immunocompetent organotypic lymphoid aggregate structures. This highly efficient and versatile workflow for gene editing of tonsillar CD4 T cells enables the dissection of molecular mechanisms in ex vivo cultures of human lymphoid tissue and can be adapted to other tonsil-resident cell types. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=170 SRC="FIGDIR/small/554089v1_ufig1.gif" ALT="Figure 1"> View larger version (32K): org.highwire.dtl.DTLVardef@1ece503org.highwire.dtl.DTLVardef@1af2d0corg.highwire.dtl.DTLVardef@1b67f14org.highwire.dtl.DTLVardef@510d63_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: CITE-seq
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples
A. Eerkens, A. Vledder, … M. de Bruyn·bioRxiv·Nov 12, 2021
- Naive and in vitro-activated primary mouse CD8+ T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering
P. Pfenninger, L. Yerly, J. Abe·bioRxiv·Sep 14, 2021
- A CRISPR-Cas9 Genome Engineering Platform in Primary CD4+ T Cells for the Interrogation of HIV Host Factors
Judd F. Hultquist, Joseph B Hiatt, … Nevan J. Krogan·bioRxiv·Oct 19, 2017
- Protocol for Non-viral HDR-based CRISPR/Cas9 platform for small custom editing in primary T cells
Katariina Mamia, Anniken Solveig Matheson Sollano, … Emma Maria Haapaniemi·Frontiers in Genome EditingPeer-reviewed·Sep 30, 2026
- Programming primary human T cells to deliver gene editing machinery
James Meixiong, Oleksandr Zginnyk, … Matthew H. Spitzer·bioRxiv·Oct 2, 2026
- Highly efficient and versatile plasmid-based gene editing in primary T cells
M. Kornete, R. Marone, L. T. Jeker·bioRxiv·Jan 13, 2018